News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
241 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (22652)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (7)
2 (15)
3 (243)
4 (292)
5 (235)
6 (83)
7 (4)
8 (20)
9 (229)
10 (249)
11 (163)
12 (210)
13 (72)
14 (2)
15 (29)
16 (196)
17 (228)
18 (224)
19 (189)
20 (95)
21 (7)
22 (4)
23 (193)
24 (210)
25 (262)
26 (241)
27 (78)
28 (20)
29 (55)
30 (184)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Business
Company Profile for Mirum Pharmaceuticals
The company’s lead product candidate, maralixibat, is an investigational oral drug in development for progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome (ALGS).
September 26, 2019
·
1 min read
BioMidwest
Millendo Therapeutics to Present at Prader-Willi Syndrome Conferences
Presentations on livoletide and PWS at the Foundation for Prader-Willi Research Annual Research Symposium and Family Conference and the Prader-Willi Syndrome Association USA National Convention
September 26, 2019
·
10 min read
Biotech Beach
Health Technology, Medicaid Take Center Stage at First Annual ConsejoSano Conference
Health Care and Tech Leaders, Investors, Policy Makers on Texting to Help Low-Income, Multicultural Populations
September 26, 2019
·
2 min read
Business
InsightRX Welcomes Two New Expert Specialists to Its Expanding Team
Dunnie Norman and Andro Hsu join the company’s senior leadership team as SVP of Sales and Director of Marketing, further elevating InsightRX’s strategic brand development and commercialization
September 26, 2019
·
2 min read
Biotech Bay
GenomeSmart™ Announces Availability of GenoWatch™ to Improve Integration of Genetic Risk and Assessment Services with Routine Primary Care and Population Health Initiatives
The “command central” dashboard helps clinicians identify and prioritize patients who would benefit from genetic testing and implement a simplified genetic testing workflow
September 26, 2019
·
3 min read
Newronika Raises an 8.4M EUR Series-A Round
F3F and an undisclosed family office also participated in the syndication.
September 26, 2019
·
2 min read
Business
New Study Finds Parents of Infants with Sleep Trouble Have Increased Risk of Daytime Dysfunction
Flinders University partners with Nanit to understand how infant sleep affects the whole family
September 26, 2019
·
3 min read
Biotech Beach
Heart Attack Survivors Are Taking Steps To Reduce Their Cardiovascular Risk. But Are They The Right Ones?
This World Heart Day, Amgen is Releasing Results of a Global Survey of 3,200 Heart Attack Survivors Conducted Across 13 Countries Close to Half of Survivors Are Not Monitoring Their Cholesterol Regularly
September 26, 2019
·
11 min read
Business
3D Systems’ VSP Orthopaedics Receives FDA 510(k) Clearance -- Opening the Door to Personalized Treatment of Complex Musculoskeletal Disease
3D Systems (NYSE: DDD) announced that the Food and Drug Administration (FDA) has provided 510(k) clearance to its new VSP Orthopaedics solution -- enabling surgeons to obtain a clear 3D visualization of a patient’s anatomy and develop a personalized surgical plan, prior to entering the operating room.
September 26, 2019
·
5 min read
Smith+Nephew introduces ground-breaking assurance program for TRIGEN™ INTERTAN™ Intertrochanteric Hip Fracture Nail
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announced the launch of its new INTERTAN Product Assurance (IPA) Program at the Orthopaedic Trauma Association Annual Meeting in Denver, CO.
September 26, 2019
·
5 min read
Previous
18 of 25
Next